J.W. Cole Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
J.W. Cole Advisors's AMGN Position: Q2 2026 in Review
J.W. Cole Advisors reduced its Amgen (AMGN) stake by 0.91% in Q2 2026, selling an estimated $52K and leaving 16,509 shares worth $5.98M. The position accounts for 0.1% of the portfolio, ranked #200.
J.W. Cole Advisors first reported a position in AMGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $6.7M in Q2 2025. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- J.W. Cole Advisors held 16,509 shares of Amgen worth $5.98M as of Q2 2026.
- J.W. Cole Advisors sold 152 Amgen shares in Q2 2026, an estimated $52K.
- Amgen made up 0.1% of J.W. Cole Advisors's portfolio in Q2 2026, its #200 holding.
- J.W. Cole Advisors first reported a position in Amgen in Q4 2019 and has held it in 25 quarters since.
- J.W. Cole Advisors's Amgen position peaked at $6.7M in Q2 2025.
- 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.